Pulmonary Fibrosis Awareness - 4
Narrator: This is NIH Health Matters, I’m Joe Balintfy. Idiopathic pulmonary fibrosis or IPF is a lung condition with unknown causes and currently no cure. Dr. James Kiley at the NIH says clinical trials are under way.
Kiley: one of them looking at current ways to manage IPF through pharmacotherapy, another looking at carbon monoxide as a treatment for IPF. So there are a number of trials going on that are addressing the problem. We also know that the pharmaceutical industry is very interested in this disease and they’re conducting a couple of trials of some very novel agents that may be prospects for the future.
Narrator: For more on IPF visit www.nhlbi.nih.gov. Health Matters is produced by the National Institutes of Health, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.